Hydrogen Gas Inhalation Alleviates Airway Inflammation and Oxidative Stress on Ovalbumin-Induced Asthmatic BALB/c Mouse Model.
Wenjing He, Md Habibur Rahman, Johny Bajgai, Sofian Abdul-Nasir, Chaodeng Mo, Hui Ma, Seong Hoon Goh, Kim Bomi, Hyeran Jung, Cheol-Su Kim, Hyungdon Lee, Kyu-Jae Lee · Antioxidants (Basel, Switzerland) · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In female BALB/c mice, contrarily, treatment with 3% H₂ significantly increased the GPx activity in the HT group compared to that in the NC group ( p < 0.001; Figure 5 C), suggesting its protective role against oxidative damage in airway inflammation. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in female BALB/c mice. Contrarily, treatment with 3% H₂ significantly increased the GPx activity in the HT group compared to that in the NC group ( p < 0.001; Figure 5 C), suggesting its protective role against oxidative damage in airway inflammation.
What the Researchers Studied
The researchers studied female BALB/c mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 3% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 3% source-reported H₂ gas concentration; reported treatment duration: 30 min. Contrarily, treatment with 3% H₂ significantly increased the GPx activity in the HT group compared to that in the NC group ( p < 0.001; Figure 5 C), suggesting its protective role against oxidative damage in airway inflammation. The authors concluded that H₂ inhalation is a promising treatment option for airway inflammation, offering a novel approach with potential clinical applications. Molecular hydrogen (H₂) has recently been recognized for its antioxidant and anti-inflammatory properties.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was female BALB/c mice. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 3% source-reported H₂ gas concentration. The reported treatment duration was 30 min.
Limitations and Safety
Safety information: In this study, the researchers used an allergic asthmatic mouse model, and the results demonstrated that treating airway inflammation with 3% H₂ is safe, well tolerated, and free of adverse effects.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.